|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
ZEN Graphene Solutions - Graphene-Enhanced Materials for Next-Level Performance
ZEN’s patent-pending graphene-based biocidal coating has 99%+ proven effectiveness against viruses, fungi and bacteria.
We are working with TreborRx and other partners globally to bring this much needed innovation forward to better protect our healthcare workers and the public.
“Trebor is excited to be launching a new, game changing, 4-ply mask technology with our partners at ZEN.” George Irwin, TreborRX CEO
ZEN is evaluating development of a rapid, ultrasensitive and low-cost bio-sensor to detect the presence of the SARS-CoV-2 antigens and potentially others.
ZEN Graphene Solutions Announces Exclusive Worldwide Rights to Commercialize Rapid, Saliva-Based COVID-19 Antigen Testing Technology zengraphene.com
With 99.9% effectiveness against bacteria, fungi and viruses, the ability to achieve those levels with an extremely low minimum inhibitory concentration (MIC) and excellent safety results, ZEN’s patent-pending graphene-based formulation is a potential game changer for treating human-contracted pathogens and infectious disease management.
“In the clinical setting, if the compound can be shown to be safe and effective, it could provide a breakthrough alternative therapy with potentially significant impact on the practice of family medicine.” Dr. Tony Mazzulli, MD, FRCPC, FACP, Microbiologist-in-Chief and Infectious Disease Specialist at University Health Network/Mount Sinai Hospital
Corporate Presentations: zengraphene.com
|© 2021 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|